1. 1. Younossi ZM, Stepanova M, et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 2011;9(6):524-530. e1.
2. 2. Chalasani N, Younossi Z, et al. The diagnosis and management of non alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012;55(6):2005-2023.
3. 3. Baffy Gr, Brunt EM, et al. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol. 2012;56(6):1384- 1391.
4. 4. Ashtari S, Pourhoseingholi MA, et al. Non-alcohol fatty liver disease in Asia: Prevention and planning. World J Hepatol 2015;7(13):1788.
5. 5. Fan JG, Zhu J, et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China J Hepatol 2005;43(3):508-514.